Table 1.
Antibody domain | Number of Sites Scanned | % Scanned Sites Expressed as mAbsa | % of Expressed mAbs Conjugatedb | % of High DAR Conjugatesc | % of Highly Monomeric High DAR ADCsd | Total Number of Manufacturable Sitese | % of Manufacturable Sites Per Sites Scanned |
---|---|---|---|---|---|---|---|
Light chain constant region | 106 | 75 | 50 | 22 | 88 | 14 | 13 |
Heavy chain CH1 | 98 | 99 | 70 | 46 | 51 | 23 | 23 |
Heavy chain Hinge | 15 | 100 | 87 | 40 | 0 | 0 | 0 |
Heavy chain CH2 | 110 | 57 | 60 | 35 | 27 | 6 | 5 |
Heavy chain CH3 | 107 | 80 | 72 | 37 | 44 | 14 | 13 |
All constant regions (light and heavy chain) | 436 | 76 | 68 | 37 | 49 | 58 | 13 |
aTiters ≥ 10 mg/L (light chain) or ≥ 80 mg/L (heavy chain) and purifiable by Protein A.
bAnalyzable ADCs with DARs ≥ 0.5.
cADCs with DARs above 1.3 (light chain) or 1.5 (heavy chain)
dOf High DAR conjugated antibodies, % monomer above 95.
eNumber of highly monomeric, high DAR ADCs produced per number of sites scanned.